BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26503042)

  • 1. CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase.
    He W; Bai G; Zhou H; Wei N; White NM; Lauer J; Liu H; Shi Y; Dumitru CD; Lettieri K; Shubayev V; Jordanova A; Guergueltcheva V; Griffin PR; Burgess RW; Pfaff SL; Yang XL
    Nature; 2015 Oct; 526(7575):710-4. PubMed ID: 26503042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy.
    Mo Z; Zhao X; Liu H; Hu Q; Chen XQ; Pham J; Wei N; Liu Z; Zhou J; Burgess RW; Pfaff SL; Caskey CT; Wu C; Bai G; Yang XL
    Nat Commun; 2018 Mar; 9(1):1007. PubMed ID: 29520015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis.
    Sleigh JN; Gómez-Martín A; Wei N; Bai G; Yang XL; Schiavo G
    Sci Rep; 2017 Aug; 7(1):9216. PubMed ID: 28835631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
    Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
    Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
    Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
    Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice.
    Sleigh JN; Grice SJ; Burgess RW; Talbot K; Cader MZ
    Hum Mol Genet; 2014 May; 23(10):2639-50. PubMed ID: 24368416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT2-knockdown rescues GARS-induced Charcot-Marie-Tooth neuropathy.
    Zhao Y; Xie L; Shen C; Qi Q; Qin Y; Xing J; Zhou D; Qi Y; Yan Z; Lin X; Dai R; Lin J; Yu W
    Aging Cell; 2021 Jun; 20(6):e13391. PubMed ID: 34053152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect.
    Nangle LA; Zhang W; Xie W; Yang XL; Schimmel P
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11239-44. PubMed ID: 17595294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
    Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
    J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by
    Sleigh JN; Dawes JM; West SJ; Wei N; Spaulding EL; Gómez-Martín A; Zhang Q; Burgess RW; Cader MZ; Talbot K; Yang XL; Bennett DL; Schiavo G
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3324-E3333. PubMed ID: 28351971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D).
    Seo AJ; Shin YH; Lee SJ; Kim D; Park BS; Kim S; Choi KH; Jeong NY; Park C; Jang JY; Huh Y; Jung J
    J Mol Histol; 2014 Apr; 45(2):121-8. PubMed ID: 23990368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase.
    Zuko A; Mallik M; Thompson R; Spaulding EL; Wienand AR; Been M; Tadenev ALD; van Bakel N; Sijlmans C; Santos LA; Bussmann J; Catinozzi M; Das S; Kulshrestha D; Burgess RW; Ignatova Z; Storkebaum E
    Science; 2021 Sep; 373(6559):1161-1166. PubMed ID: 34516840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plexin-Semaphorin Signaling Modifies Neuromuscular Defects in a
    Grice SJ; Sleigh JN; Zameel Cader M
    Front Mol Neurosci; 2018; 11():55. PubMed ID: 29520219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Sensory Neuron Development in CMT2D Mice Is Site-Specific and Linked to Increased GlyRS Levels.
    Sleigh JN; Mech AM; Aktar T; Zhang Y; Schiavo G
    Front Cell Neurosci; 2020; 14():232. PubMed ID: 32848623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology.
    Grice SJ; Sleigh JN; Motley WW; Liu JL; Burgess RW; Talbot K; Cader MZ
    Hum Mol Genet; 2015 Aug; 24(15):4397-406. PubMed ID: 25972375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.
    Motley WW; Seburn KL; Nawaz MH; Miers KE; Cheng J; Antonellis A; Green ED; Talbot K; Yang XL; Fischbeck KH; Burgess RW
    PLoS Genet; 2011 Dec; 7(12):e1002399. PubMed ID: 22144914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
    Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
    Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation in the GARS gene in a Malian family with Charcot-Marie-Tooth disease.
    Yalcouyé A; Diallo SH; Coulibaly T; Cissé L; Diallo S; Samassékou O; Diarra S; Coulibaly D; Keita M; Guinto CO; Fischbeck K; Landouré G;
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00782. PubMed ID: 31173493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
    Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
    Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS.
    Sun L; Wei N; Kuhle B; Blocquel D; Novick S; Matuszek Z; Zhou H; He W; Zhang J; Weber T; Horvath R; Latour P; Pan T; Schimmel P; Griffin PR; Yang XL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.